AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Nifedipine in Zambia
5 products registered with ZAMRA — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Nifedi-Denk 20 Retard tablets Prolonged release tablets | 130/002 | Denk Pharma GmbH & Co. KG | active | 1 Jul 2030 |
| Carditas retard tablets Tablet Film coated | 085/019 | Intas Pharmaceuticals Limited | active | 8 Mar 2030 |
| Nifetab 20 tablets Tablet extended release | 249/016 | Saga Lifesciences Limited | active | 20 Nov 2029 |
| Nifedi-Denk 10 Retard tablets Prolonged release tablets | 130/001 | Denk Pharma GmbH & Co. KG | active | 27 Oct 2029 |
| Nifedipine Tablets 10mg Tablet Uncoated | 192/031 | Macleods Pharmaceuticals Limited | active | 7 Jun 2029 |
Nifedipine — ZAMRA Registration Details
ZAMRA (Zambia) has 5 registered products containing Nifedipine, of which 5 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Nifedipine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.